Windsor James Brian

Windsor James Brian is listed in filings as See Remarks at Rein Therapeutics Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including purchase activity. Recent filings connect the profile to Rein Therapeutics Inc. (RNTX). The current snapshot covers public activity from May 13, 2026. Reported amounts are shown as $175.5K to $25.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.